Literature DB >> 33413921

The role of bone marrow microRNA (miR) in erythropoietic dysfunction after severe trauma.

Camille G Apple1, Elizabeth S Miller1, Kolenkode B Kannan1, Julie A Stortz1, Tyler J Loftus1, Maria Cecilia Lopez2, Hari K Parvataneni3, Matthew Patrick3, Jennifer E Hagen3, Henry V Baker2, Philip A Efron1, Alicia M Mohr4.   

Abstract

BACKGROUND: Previous data has shown that severe traumatic injury is associated with bone marrow dysfunction, which manifests as persistent injury-associated anemia. This study sought to identify whether the expression of erythropoiesis-related microRNAs were altered in the bone marrow of trauma patients to determine if these microRNAs play a role in persistent injury-associated anemia.
METHODS: Bone marrow was collected from severely injured trauma patients who underwent fracture fixation as well as patients who underwent elective hip replacement. There were 27 trauma patients and 10 controls analyzed. Total RNA and microRNA were isolated from CD34-positive cells using the RNeasy Plus Mini kit, and genome-wide microRNA expression patterns were assayed. Genes with significant expression differences were found using BRB-ArrayTools with a significance of P < .01.
RESULTS: There were marked differences in expression of 108 microRNAs in the trauma group when compared with hip replacement patients. Four of these microRNAs play a role in regulating erythropoiesis: microRNA-150, microRNA-223, microRNA15a, and microRNA-24. These microRNAs were all upregulated significantly, with trauma/hip replacement fold changes of 1.7, 1.8, 1.2, and 1.2 respectively, and all act to suppress or regulate erythropoiesis.
CONCLUSION: Assessment of the bone marrow microRNA profile in trauma patients compared to those undergoing elective hip replacement revealed the differential expression of microRNA-150, microRNA-223, microRNA-15a, and microRNA-24. These microRNAs all play a role in decreased erythroid progenitor cell growth and provide important insight to the erythropoietic dysfunction seen after trauma.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33413921      PMCID: PMC8107112          DOI: 10.1016/j.surg.2020.11.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

Review 1.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

2.  The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6.

Authors:  Rodrigo B Fonseca; Alicia M Mohr; Lai Wang; Ziad C Sifri; Pranela Rameshwar; David H Livingston
Journal:  J Trauma       Date:  2005-10

3.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

4.  The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.

Authors:  A J Warren; W H Colledge; M B Carlton; M J Evans; A J Smith; T H Rabbitts
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr
Journal:  Surgery       Date:  2015-07-21       Impact factor: 3.982

6.  Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis.

Authors:  M Shiozaki; R Sakai; M Tabuchi; T Nakamura; K Sugino; H Sugino; Y Eto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.

Authors:  Nadia Felli; Francesca Pedini; Paolo Romania; Mauro Biffoni; Ornella Morsilli; Germana Castelli; Simona Santoro; Simona Chicarella; Antonio Sorrentino; Cesare Peschle; Giovanna Marziali
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

8.  An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling.

Authors:  Taro Fukao; Yoko Fukuda; Kotaro Kiga; Jafar Sharif; Kimihiro Hino; Yutaka Enomoto; Aya Kawamura; Kaito Nakamura; Tsutomu Takeuchi; Masanobu Tanabe
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

9.  MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4.

Authors:  Qiang Wang; Zheng Huang; Huiling Xue; Chengcheng Jin; Xiu-Li Ju; Jing-Dong J Han; Ye-Guang Chen
Journal:  Blood       Date:  2007-09-28       Impact factor: 22.113

10.  MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.

Authors:  Jun Lu; Shangqin Guo; Benjamin L Ebert; Hao Zhang; Xiao Peng; Jocelyn Bosco; Jennifer Pretz; Rita Schlanger; Judy Y Wang; Raymond H Mak; David M Dombkowski; Frederic I Preffer; David T Scadden; Todd R Golub
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.